Health & Fitness

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, new research indicates. The study found that male rats who received the drug ifosfamide during adolescence had offspring and grand-offspring with increased incidence of disease. While other research has shown that cancer treatments can increase patients' chance of developing disease later in life, this is one of the first-known studies showing that susceptibility can be passed down to a third generation of unexposed offspring.

from Top Health News -- ScienceDaily https://ift.tt/ipy5BxG

Scientists fear that viruses frozen for over 50,000 years could once again rear their heads as the ice melts and the cells are released from their preservation.

from Health | body+soul https://ift.tt/LjfkUO9

Researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/dRG8NPs

Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide. Although symptomatic medications are available, one-third of TLE patients remain unresponsive to current treatment, so new drug targets are critically needed. Neuroscientist have recently identified and developed a new drug candidate that has potential for effectively treating TLE by suppressing neuroinflammation.

from Top Health News -- ScienceDaily https://ift.tt/9ZJWDPQ

Nearly 1 in 7 Americans experience bloating on a weekly basis, and most aren't seeking professional care for it, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/RCK0ZyA

Understanding how bats tolerate viral infections without developing symptoms may lead to better ways of combating human disease.

from Top Health News -- ScienceDaily https://ift.tt/43FGfOI

In a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy. Instead, clinicians need to understand how immune cells and tumors are interacting within a patient, rather than simply the levels of each associated proteins present, to prescribe the best treatment.

from Top Health News -- ScienceDaily https://ift.tt/WkJDRv6